Pfizer secures up to $1.5B to test a monthly GLP-1 shot

commentaryThe Rundown AINov 16, 2026

Blackstone will fund up to $1.5B for Pfizer’s experimental monthly GLP-1 drug as larger trials test whether fewer injections can sustain weight loss.

Impact: LowConfidence: MediumNovelty: Incremental
commentarythe-rundown-ai

See the whole story

Read the original on The Rundown AI

Sens.ai aggregates and assesses published reporting. The assessment above is machine generated; the original source is authoritative.